| Description |
1 online resource (1 PDF file (11 pages)). |
| Physical Medium |
polychrome |
| Description |
text file |
| Series |
Occasional paper
|
|
Occasional paper (Rand Corporation)
|
| Note |
Title from PDF caption. |
| Bibliography |
Includes bibliographical references. |
| Summary |
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value. |
| Contents |
Medicines as a Service. |
| Local Note |
JSTOR Books at JSTOR Open Access |
|
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
Pharmaceutical services.
|
|
Pharmaceutical services. |
|
Pharmaceutical industry.
|
|
Pharmaceutical industry. |
|
Mathematical models.
|
|
mathematical models. |
|
Mathematical models. |
|
MEDICAL -- Pharmacology. |
| Genre/Form |
Electronic books.
|
| Added Author |
Klautzer, Lisa.
|
|
Mengistu, Tewodaj.
|
|
RAND Health.
|
| Other Form: |
Print version: Mattke, Soeren. Medicines as a Service : A New Commercial Model for Big Pharma in the Postblockbuster World. Santa Monica : RAND Corporation, ©2012 |
| ISBN |
9780833076465 |
|
0833076469 |
|
9780833076458 (electronic book) |
|
0833076450 (electronic book) |
|
